01 1Alivus Life Sciences
01 1RANOLAZINE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-06
Pay. Date : 2021-05-25
DMF Number : 32573
Submission : 2018-03-29
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RANOLAZINE, with a corresponding US DMF Number 32573.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 06, 2021, and payment made on May 25, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
